Nuclithera AS is a Norwegian AS based in Oslo, operating in the Research and experimental development on natural sciences and engineering sector. Incorporated in 2023, the company has 9 employees and reported revenue of NOK 4.9m in its latest annual filing.
Utvikling av medisinske produktkandidater, herunder utvikling og utlisensiering av patenter og andre rettigheter, samt utleie av laboratorieutstyr og konsulenttjenester, og annen virksomhet som har naturlig tilknytning til dette. Selskapet kan eie aksjer og andeler i andre selskaper med lignende virksomhet.
In its most recent annual report (2025), Nuclithera AS reported revenue of NOK 4.9m, an increase of 54% on the year before. The figures on this page draw on 3 annual filings covering 2023 to 2025. The bottom line showed a net loss of NOK 2.1m, and the EBITDA margin stood at -44.4%.
At the end of 2025, equity financed 80% of the balance sheet, and current assets covered short-term debt 5 times.
Frequently asked questions
What is the Org number of Nuclithera AS?
Nuclithera AS is registered with Brønnøysundsregistrene under Org 832728462.
What is the revenue of Nuclithera AS?
Nuclithera AS reported revenue of NOK 4.9m in 2025.
How many employees does Nuclithera AS have?
Nuclithera AS employs 9 people as of the latest annual report.
Who is the CEO of Nuclithera AS?
Ludvik Sandnes is the CEO of Nuclithera AS, in role since 2024.
Who is the chairman of Nuclithera AS?
Roy Hartvig Larsen chairs the board of Nuclithera AS.
Where is Nuclithera AS headquartered?
Nuclithera AS's registered address is Kjelsåsveien 168B.
